Evidence map›Paper›PMID 37686965›Full record

ReviewNanomaterials (Basel, Switzerland)2023

Engineering Materials and Devices for the Prevention, Diagnosis, and Treatment of COVID-19 and Infectious Diseases.

Jennifer Soto, Chase Linsley, Yang Song, Binru Chen, Jun Fang, Josephine Neyyan, Raul Davila, Brandon Lee, Benjamin Wu, Song Li

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Jennifer SotoDepartment of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, USA.
Chase LinsleyDepartment of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, USA.ORCID 0000-0002-8259-5487
Yang SongDepartment of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, USA.
Binru ChenDepartment of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, USA.
Jun FangDepartment of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, USA.
Josephine NeyyanDepartment of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, USA.
Raul DavilaDepartment of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, USA.
Brandon LeeDepartment of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, USA.ORCID 0000-0002-0908-2319
Benjamin WuDepartment of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, USA.
Song LiDepartment of Bioengineering, University of California Los Angeles, Los Angeles, CA 90095, USA.ORCID 0000-0002-4760-8828
University of California, Los Angeles · US

Funding

Therapeutic microneedles for localized treatment of periodontal tissueR56DE029157 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LI, SONG · 2019 to 2019
$286k
NIDCR NIH HHS R56 DE029157
6 · The paper itself

Abstract

Following the global spread of COVID-19, scientists and engineers have adapted technologies and developed new tools to aid in the fight against COVID-19. This review discusses various approaches to engineering biomaterials, devices, and therapeutics, especially at micro and nano levels, for the prevention, diagnosis, and treatment of infectious diseases, such as COVID-19, serving as a resource for scientists to identify specific tools that can be applicable for infectious-disease-related research, technology development, and treatment. From the design and production of equipment critical to first responders and patients using three-dimensional (3D) printing technology to point-of-care devices for rapid diagnosis, these technologies and tools have been essential to address current global needs for the prevention and detection of diseases. Moreover, advancements in organ-on-a-chip platforms provide a valuable platform to not only study infections and disease development in humans but also allow for the screening of more effective therapeutics. In addition, vaccines, the repurposing of approved drugs, biomaterials, drug delivery, and cell therapy are promising approaches for the prevention and treatment of infectious diseases. Following a comprehensive review of all these topics, we discuss unsolved problems and future directions.

Indexed as

3D printingbiofabricationbiomaterialsdisease modelingorgan-on-a-chippoint-of-care diagnostics

Identifiers

PMID37686965
PMCPMC10490511
OpenAlexW4386283259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.